PO-0855: Flattening Filter Free VMAT for extreme hypofractionation of prostate cancer  by Ahlström, M. et al.
ESTRO 35  2016                                                                                                                                                  S407 
________________________________________________________________________________ 
(PTV) was created adding a margin of 5 mm to the ITV .The 
dose distribution was optimized on the average CT 
prescribing a dose of 20 Gy per fraction delivering a total 
dose of 60 Gy to the PTV. The plans were calculated in a 
Phillips Pinnacle 9.10 planning system using conformal 3DRT 
and heterogeneity correction. The parameters obtained in 
the average CT optimized plan, were copied to the different 
image sets with identical monitor units to analyze the 
differences. 
 
Results: The average GTV volume was 1.6 ± 1.1 cc. The ITV 
size is twice the lesion size in most of the cases except in 
those with higher breathing amplitude. The ITVs outlined in 
the average CT were smaller than those outlined in the 4DCT 
ranging from 0.1 cc, where there hardly was lesion 
movement, to 0.6 cc. The differences between the volumes 
were usually found in the cranio-caudal direction due to the 
higher movement of the lesion in this direction. The ITVs 
outlined in the MIP CT were equivalent to the 4DCT except in 
the cases where there was a higher density organ in the 
vicinity of the tumor. Respect to dose distribution, the dose 
of the organs at risk shows no significant differences in the 
different image sets. The V100 of the ITV presents significant 
variations up to 15% due to the variation in electron densities 
depending on the CT mode chosen. The V100 of the GTV 
calculated in each phase is greater than 97%. 
 
 
 
Conclusion: We recommend using the ten phases of the 4DCT 
study for proper delineation of ITV. If the institution does not 
have the technology the CT average (low pitch CT) could be 
used selecting the appropriate window level and increasing 
margins. There is no significant difference in dose to organs 
at risk between the images modalities studied. Optimized 
planning in the average CT provides adequate coverage of 
GTV at different breathing phases. 
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Purpose or Objective: Stereotactic radiosurgery alone has 
become a popular treatment option in the management of 
patients with brain metastases. Multi- or single-isocenter 
dynamic conformal arcs (DCA) and volumetric modulated arc 
therapy (VMAT) are two common used delivery techniques. 
Recently, a dedicated inverse optimized brain metastases 
treatment planning solution using single isocenter multiple 
DCA (SIDCA) has been developed, with intend to carefully 
balance normal tissue protection, target coverage and 
treatment speed. The purpose of the current study was to 
investigate the feasibility of this novel software and to 
benchmark it against well-established multi-isocenter DCA 
and single isocenter VMAT approaches. 
 
Material and Methods: Ten previously treated patients were 
selected representing a variable number of lesions (1-8), 
range of target sizes and shapes most frequently observed in 
the practice of SRS for brain metastases. The original multi-
isocenter DCA (MIDCA) were replanned with both single-
isocenter VMAT approach and the novel brain metastases tool 
(Elements, Brainlab AG, Germany). The treatment dose was 
20 Gy at the 80% prescription isodose. For all the plans, the 
dose to the surrounding healthy brain tissue (brainstem, 
cochlea, optical nerve, eyes and lens) was optimized to 
minimize normal tissue complications. The plans were 
evaluated by calculation of Paddick conformity and gradient 
index, and the volume receiving 10 and 12 Gy indicating risk 
of radionecrosis. 
 
Results: All plans were judged clinically acceptable, but 
differences were observed in the dosimetric parameters. The 
mean conformity of the automated single-isocenter planning 
tool (SIDCA) compared similarly to the established MIDCA and 
VMAT treatment techniques (CISIDCA=0.65 ± 0.08, 
CIMIDCA=0.66 ±0.07 and CIVMAT=0.67 ±0.16). Comparable 
mean dose fall off was observed between SIDCA and MIDCA 
(GISIDCA =3.9 ± 1.4 and GIMIDCA=4.5 ± 1.6). On the other 
hand, the GI of the VMAT plans (GIVMAT=7.1 ± 3.1) were 
significantly higher compared to the SIDCA. The V10 and V12 
were significantly higher for VMAT plans (V10VMAT=67.9 
±55.9cc, V12VMAT=46.3 ±35.9cc) (p<0.05) compared to 
MIDCA (V10MIDCA=49.0 ±38.1cc, V12MIDCA=35.6 ±26.4cc) and 
SIDCA (V10=48.5 ± 35.9cc, V12=36.3 ± 27.1cc). 
 
Conclusion: The automated brain metastases treatment 
planning element, based on an inversely-optimized SIDCA 
approach, revealed comparable results to the general 
accepted MIDCA approach. By reducing the time on planning, 
patient and treatment setup, this software tool improves the 
planning and delivery efficiency while preserving the plan 
quality of the MIDCA technique and lowering low dose spread 
of the VMAT approach, suggesting that this novel software 
offers the best of both worlds (i.e. efficient single-isocenter 
DCA delivery). 
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Purpose or Objective: To examine the feasibility of 
flattening filter free (FFF) volumetric modulated arc therapy 
(VMAT) for extreme hypofractionation of prostate cancer and 
investigate the potential decrease in treatment time per 
fraction while preserving or improving the treatment quality. 
To investigate the impact of intrafractional prostatic 
displacement. 
 
Material and Methods: Single arc treatment plans with 
photon beam qualities 10 MV with flattening filter (FF), 6 MV 
FFF and 10 MV FFF were created for nine patients treated 
with conventional fractionation (78 Gy, 2 Gy/fraction) and 
hypofractionation (42.7 Gy, 6.1 Gy/fraction), respectively. 
Dose-volume histograms (DVH) for all beam qualities were 
statistically evaluated using a paired sample Student’s t-test. 
Treatment delivery was evaluated through measurements on 
a Varian TrueBeam™ using a Delta4 PT system (ScandiDos AB). 
The beam-on time for each plan was recorded. A motion 
study, including one FF and one FFF hypofractionated 
treatment plan, was also performed using the HexaMotion 
(ScandiDos AB) and with trajectory data from six authentic 
prostate movement patterns. 
 
Results: All treatment plans were approved by a senior 
radiation oncologist. Evaluating the DVHs, no significant 
differences between beam qualities or between fractionation 
schedules were observed. All objectives were met for all 
plans. At the treatment delivery all plans passed the gamma 
criterion 3%, 2 mm with a pass rate of 98.8% or higher. The 
beam-on time for all conventional treatment plans was 1.0 
minute. The mean beam-on time was 2.3 minutes for the 
hypofractionated 10 MV FF plan, 1.3 minutes for the 6 MV FFF 
and 1.0 minute for the 10 MV FFF. In the motion study, no or 
little effect was observed on the pass rate for displacements 
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≤1mm. The shorter treatment delivery was superior for three 
patterns, while the longer treatment was preferred in the 
case of temporal displacement of the prostate. 
 
Conclusion: The treatment time for extreme 
hypofractionation of prostate cancer is reduced to less than 
half the time per fraction by combining FFF-technique with 
VMAT. The treatment plan quality was preserved for the FFF 
beams. Finally, a shorter beam-on time also seems 
advantageous for the majority of prostate motion patterns 
investigated. 
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Purpose or Objective: With increased 5 years survival of 
children with medulloblastoma, optimization of radiotherapy 
treatment to avoid iatrogenic sequelae has become a primary 
issue. Clinical and dosimetric characteristics of VMAT 
Craniospinal Irradiation (CSI) were studied and compared 
with the 3DCRT technique in use since 1997 at our institution 
with excellent clinical results. The impact of a setup error on 
dose distribution was also studied. 
 
Material and Methods: CT images of 8 pts that received CSI 
at our institution (23.4 Gy in 13 fractions) were used for the 
dosimetric study. For each patient, a standard 3DCRT 
treatment and a VMAT were planned. PTV dosimetric 
objectives for treatment planning were: D95% >95%, D100% 
>90%, D5% <107%. The resulting DVHs were analyzed 
considering: conformity index (CI) and homogeneity index 
(HI) for PTV, mean dose (Dmean) and D2% for OARs (small 
bowel, kidneys, heart, liver, stomach, lenses, thyroid, lungs) 
and V2Gy of non target tissues as an integral dose index. The 
data were then compared using paired Student’s t test. The 
dependence of dose indexes on patient size was evaluated. A 
3 mm longitudinal error in patient setup was simulated for 
both techniques to evaluate dosimetric impact in the 
junction region. 
 
Results: Dosimetric objectives were always met. All VMAT 
treatment plans had better HI and CI independently of 
patient size. Dmean and D2% of heart and thyroid were 
significantly lower with VMAT. On average, for heart Dmean 
was 9.8±3.4 Gy and 6.3±1.0 Gy, and D2% was 20.3±4.1Gy and 
10.4±1.7 Gy, for 3DCRT and VMAT respectively, while for 
thyroid Dmean was 18.2±1.2 Gy and 13.8±1.8 Gy, and D2% 
was 20.4±1.2 Gy and 17.4±2.0 Gy, for 3DCRT and VMAT 
respectively. On the contrary, lung dose was higher with 
VMAT: on average Dmean was 1.8±0.9 Gy for 3DCRT and 
3.5±0.8 Gy for VMAT. A 3 mm gap at field junction level 
resulted in an underdosage of about 20% for VMAT and 50% 
for 3DCRT, while a 3 mm overlap gave rise to a hotspot on 
the spine up to 30% for VMAT and 70% for 3DCRT. V2Gy was 
about 3 times higher for VMAT. 
 
Conclusion: VMAT allowed to achieve a more conformal and 
homogeneous dose distribution, with greater sparing of most 
OARs. Considering the risk of iatrogenic cardiopathy, 
hypothyroidism or secondary tumors to the thyroid, the dose 
reduction obtained with VMAT was significant. The clinical 
effect of the increased lung dose is not yet predictable, since 
absolute dose values were extremely low. VMAT implies a 
higher MU value for the delivery of the prescribed dose, 
possibly increasing the risk of secondary tumors. This is an 
important factor when dealing with pediatric pts. In VMAT, 
overdosage areas are greatly reduced with respect to 3DCRT, 
particularly in the junction region. The analysis of simulated 
gaps and overlaps shows that field junctions are less critical 
for VMAT, nevertheless junction moving is still mandatory to 
avoid potentially dangerous hot or cold spots. Partially 
supported by Associazione Italiana per la Ricerca sul Cancro 
(AIRC) 
 
PO-0857  
GTV-based prescription and Monte Carlo treatment 
planning in Cyberknife treatments for lung lesions 
A. Vai
1Centro Diagnostico Italiano, Cyberknife Department, Milan, 
Italy 
1,2, P. Bonfanti1, M. Invernizzi1, A. Martinotti1, I. 
Redaelli1, F. Ria1,3, R. Beltramo1, L.C. Bianchi1, I. Bossi 
Zanetti1, A. Bergantin1 
2ProgettoDiventerò Grantee, Fondazione Bracco, Milan, Italy 
3ProgettoDiventerò Alumnus, Fondazione Bracco, Milan, Italy 
 
Purpose or Objective: GTV-based prescription has been 
proposed as a possible recipe for Monte Carlo treatment 
planning in Cyberknife SBRT treatments for lung lesions 
(Lacornerie et al., 2014, [1]). The feasibility of this approach 
was investigated comparing Ray-Tracing algorithm (Effective 
Path Length method, EPL) and Monte Carlo (MC) dose 
calculation. 
 
Material and Methods: A group of 40 consecutive patients 
from July to October 2015, treated with Cyberknife SBRT 
using an advanced target tracking system (Lung Optimized 
Treatment, LOT) was considered. Primary lung cancers and 
metastatic pulmonary lesions, different tumor size (small: 
V<14cc, large: V>65cc) and locations (totally air-surrounded, 
partially air-surrounded), prescription dose and fractionation 
schemes were included in the group. Treatment plans were 
optimized using RT algorithm (RT plans), with prescription 
isodose line of 80% providing 95% PTV coverage (PTV = GTV + 
5mm), and re-calculated with MC algorithm (1x1x1 mm3 dose 
grid, uncertainty=1%), using the same beam angles and 
monitor units (MCrecalc plans). Dose parameters for RT and 
MCrecalc plans were evaluated for both GTV, PTV and OARs, 
in relation to tumor size and position. On a subset of 5 
patients, MCrecalc plans were normalized to the isodose line 
encompassing the 95% of the GTV volume (MCnorm plans) and 
compared to MC-optimized plans, with dose prescribed to the 
same isodose line (MCopt plans). 
 
Results: Difference between RT and MCrecalc plans in 
average percentage volume covered by the prescribed dose 
for GTV and PTV is 13.5% (RT: 99.6%, MC: 86.1%) and 41.8% 
(RT: 96.8%, MC: 55.0%) respectively. Dose parameters 
referred to GTV (Dmean, D50, D98, D2) have a lower 
variation compared with PTV parameters: excluding D2, D50 
shows the lowest variability for the analyzed group. 
Concerning OARs, difference in V20, V10, V5 for lungs 
(ipsilateral and contralateral) is 0.6%, 1.4% and 3.4%, 
respectively.  
